home / stock / mnov / mnov news

MNOV News and Press, MediciNova Inc. From 11/03/25

Stock Information
Company Name: MediciNova Inc.
Stock Symbol: MNOV
Market: NASDAQ
Website: medicinova.com
Menu
MNOV MNOV Quote MNOV Short MNOV News MNOV Articles MNOV Message Board
Get MNOV Alerts

News, Short Squeeze, Breakout and More Instantly...
MNOV - US Companies Moving the Markets, Morning edition
Mon, Nov 03, 2025 as of 10.00 am ET

A look at the top 10 most actives in the United States EPWK Holdings Ltd. (EPWK) rose 29.2% to $0.0855 on volume of 1,411,810,058 shares Yueda Digital Holding (YDKG) rose 21.6% to $0.0563 on volume of 591,315,290 shares UTime Limited (WTO) rose 6.9% to $0.0463 on volume of 326,794,845 share...
MNOV - US Companies Moving the Markets, Evening edition
Fri, Oct 31, 2025 as of 4:00 pm ET

A look at the top 10 most actives in the United States EPWK Holdings Ltd. (EPWK) rose 29.2% to $0.0855 on volume of 1,384,347,396 shares Yueda Digital Holding (YDKG) rose 21.6% to $0.0563 on volume of 580,113,283 shares AMTD Digital Inc. American Depositary Shares (every five of which repre...

MNOV - MediciNova Compounds Demonstrate Novel Therapeutic Approach for Atherosclerosis in Peer-Reviewed Publication

LA JOLLA, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), announces the publication of a new research article in the peer-reviewed Jo...

MNOV - MediciNova to Present at the LD Micro Main Event XIX Investor Conference

LA JOLLA, Calif., Oct. 06, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875) (the “Company”), announces that Yuichi Iwaki, M.D., Ph.D., Pres...
MNOV - MediciNova Announces Completion of Patient Enrollment in COMBAT-ALS Phase 2b/3 Clinical Trial of MN-166 (ibudilast)

LA JOLLA, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced the successful completion of patient enrollment in its Phase...

MNOV - MediciNova Announces Poster Presentation of COMBAT-ALS Clinical Trial at the 36th International Symposium on ALS/MND

LA JOLLA, Calif., Sept. 16, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that an abstract regarding the Phase 2b/3 COMBAT clinical tr...

MNOV - MediciNova Provides Shareholder Update on Key Developments

LA JOLLA, Calif., Sept. 08, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875) (the “Company”), provides a shareholder update recap...
MNOV - MediciNova to Present at the H.C. Wainwright 27th Annual Global Investment Conference

LA JOLLA, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875) (the “Company”), announces that Yuichi Iwaki, MD., Ph...

MNOV - MediciNova Achieves Enrollment in COMBAT-ALS Clinical Trial

LA JOLLA, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), announces that it successfully achieved enrollment of the target number of p...

MNOV - Expected US Company Earnings on Thursday, August 14th, 2025

Century Therapeutics Inc. (IPSC) is expected to report $-0.38 for Q2 2025 Birchtech Corp Com (BCHT) is expected to report for Q2 2025 Cellectar Biosciences Inc. (CLRB) is expected to report $-3.6 for Q2 2025 Acuren Corporation (TIC) is expected to report for quarter end 2025-06-30 ...
Previous 10 Next 10